Atlas FDA

LSK

8 FDA 510(k) clearances · Product code

183 daysmedian time to decision
806 days90th percentile
8clearances measured

FDA profile

Official device name
Dna-Reagents, Chlamydia
Device class
Class I (low risk)
Regulation
21 CFR 866.3120
Medical specialty
Microbiology
Flags
Third-party review eligible
Adverse events (MAUDE)
1996: 1 · 2002: 3
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
ABBOTT REALTIME CT/NG AND ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, MODELS 8L07-91, 9K12-03 (K092704)Abbott Molecular, Inc.2010-05-28
MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01 (K010891)Digene Corp.2001-09-25
MODIFICATION HYBRID CAPTURE II CT-ID DNA TEST, MODEL 03M91-01 (K010892)Digene Corp.2001-09-24
HYBRID CAPTURE II CT-ID TEST (K990023)Digene Corp.1999-10-25
PACE 2 CHLAMYDIA TRACHOMATIS PROBE CONFIRM ASSAY (K920302)Gen-Probe, Inc.1994-04-06
PACE 2 SYSTEM FOR CHLAMYDIA TRACHOMATIS (K920378)Gen-Probe, Inc.1992-04-29
GEN-PROBE(R) PACE(TM) SYSTEM CHLAMYDIA TRACHOMATIS (K874878)Gen-Probe, Inc.1987-12-29
RAPID DIAGNOSTIC SYSTEM FOR CHLAMYDIA TRACHOMATIS (K871878)Gen-Probe, Inc.1987-10-28

Track LSK automatically

Every clearance here is in the API, with alerts when new ones post.